|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||
Part 2: Optimization Of PD in Asia |
Division of Nephrology-Hypertension, Department of Internal Medicine, Faculty of Medicine, University of Indonesia, Jakarta, Indonesia
Correspondence to: Suhardjono, Division of Nephrology and Hypertension,
Department of Internal Medicine, Faculty of Medicine, University of Indonesia,
Jakarta,
Indonesia.
pernefri{at}cbn.net.id
Chronic kidney disease is prevalent in Indonesia, running at 29.1% in the
population at risk (hypertension, diabetes, and proteinuria). In a recent
survey, the incidence rate for end-stage renal disease (ESRD) was 30.7 per
million population (pmp), and the prevalence rate was 23.4 pmp. In 2006, about
10 000 patients were being treated with hemodialysis. Nevertheless, many ESRD
patients remained untreated. Financial problems, scarcity of dialysis
facilities, and insufficient numbers of skilled health care providers were
among reasons why renal replacement treatment is not so well developed in
Indonesia.
The continuous ambulatory peritoneal dialysis (CAPD) program begun in 1985
was slowly growing until an economic crisis in 1998. Afterward, with new
development of CAPD and government support, the number of patients on CAPD
increased. In the middle of 2007, CAPD patients numbered 774 in total.
Drop-out rates remained high, because of death, infection, and catheter
failure. Almost all new CAPD patients are older than 35 years of age, and the
technique is still costly: 51% of patients receive 4 daily exchanges, costing
$6000 annually; the rest receive 3 daily exchanges, costing $4800 annually.
Government insurance reimburses only 3 exchanges. Expensive drugs such as
erythropoietin, intravenous iron, and vitamin D3 are not covered by
insurance. The infection rate for the most recent year was 1 episode in 47.17
patient-months. The cost of antibiotic treatment to cure peritonitis is still
expensive. Many patients experience some complication related to catheter
obstruction or hemorrhage.
In Indonesia, CAPD is relatively new and just beginning to progress. In our
archipelago, with its many islands and limited resources and investment, CAPD
may be the better choice of therapy. More training is needed to increase the
number of skilled and experienced doctors, nurses, and other CAPD team
members. We hope that CAPD can be made more affordable for ESRD patients.
KEY WORDS: Continuous ambulatory peritoneal dialysis; developing country; end-stage renal disease.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |